Global | Coronavirus Watch: When is the vaccine tipping point?
Despite increasing numbers of new coronavirus cases globally, the possibility that more economies will enjoy both limited domestic restrictions and sustained low new case numbers is growing closer thanks to ongoing vaccination rollouts.
Indeed, the persistent decline in the number of new cases in Israel, even after the reopening of the economy in early March, implies the country has already reached the tipping point allowing fewer restrictions while maintaining lower case numbers. However, it is difficult to tell with certainty exactly when the corner was turned, and the level of immunity needed within the domestic population.
Although the UK is rapidly rolling out vaccines and is experiencing a persistent drop in case numbers, it remains unclear whether mass vaccination or persistent restrictions are leading the improving health situation. Meanwhile, the US and Chile have vaccinated a significant share of their populations but are still recording rising case numbers.
It is uncertain whether any economies other than Israel have reached the tipping point where restrictions can be eased while keeping case numbers low.
Firms must brace for higher ‘new normal’ construction material prices
New research by Oxford Economics suggests that construction materials prices have shifted permanently higher due to the shocks of the past couple of years. Project managers and investors should anticipate costs being at least 15-20% higher in 2024 and onwards than in 2021.Find Out More
New Activity Trackers suggest momentum is waning
After a choppy first quarter of GDP data, our novel Activity Trackers (which incorporate proprietary daily sentiment data from Penta) suggest that economic momentum in EM Asia is on a softer trend in Q2 (at least outside of China) supporting our view of easing underlying inflationary pressures and diminishing appetite for further rate hikes.Find Out More